Hexarelin CJC-1295 NO DAC Peptide Stack
The Hexarelin CJC-1295 No DAC Peptide Stack from Direct Anti Peptide delivers two individually lyophilised research-grade peptides at ≥98% purity, designed for qualified laboratory investigation of growth hormone secretagogue pathways. This dual-peptide combination is available for sale online and is supplied exclusively for preclinical and in-vitro scientific research. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Hexarelin Nasal Spray
Direct Anti Peptide offers Hexarelin Nasal Spray, a synthetic hexapeptide growth hormone secretagogue (GHS) formulated at ≥98% purity for advanced laboratory and preclinical research applications. Supplied in a convenient nasal spray format, this compound is rigorously quality-tested and intended exclusively for in vitro and ex vivo scientific investigation. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Hexarelin Peptide Vial
Hexarelin Peptide Vial from Direct Anti Peptide is a high-purity, lyophilized growth hormone-releasing peptide supplied at ≥98% purity for advanced laboratory and preclinical research applications. Each vial is analytically verified by HPLC and mass spectrometry, ensuring consistent quality and structural integrity across every batch. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
Hexarelin Pre-Mixed Pen 2mg Peptide
Direct Anti Peptide's Hexarelin Pre-Mixed Pen 2mg is a ≥98% purity synthetic ghrelin analogue supplied as a ready-to-use pre-mixed cartridge kit for qualified research professionals. Designed for laboratory investigations into growth hormone secretion, muscle tissue dynamics, protein synthesis, body composition, and cardioprotective mechanisms. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Frag 176-191 Ipamorelin CJC DAC
Direct Anti Peptide offers this research-grade triple-peptide blend combining HGH Fragment 176-191, Ipamorelin, and CJC-1295 DAC at ≥98% purity, formulated exclusively for in vitro and laboratory research applications. Each component contributes distinct mechanistic properties, making this blend a compelling subject for studies involving lipolysis pathways, growth hormone secretion, and sustained hormonal signaling. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Fragment 176-191 = 6mg | Ipamorelin = 3mg | CJC-1295 DAC = 3mg
HGH Frag 176-191 Ipamorelin CJC No DAC Blend
Direct Anti Peptide offers the HGH Frag 176-191 Ipamorelin CJC No DAC blend at ≥98% purity, triple-verified by HPLC and mass spectrometry, and supplied in lyophilized form for maximum stability. This multi-component research peptide blend is formulated for qualified laboratory investigators studying growth hormone axis regulation, metabolic signaling, and related physiological pathways. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Fragment & CJC-1295 Dac Nasal Spray
Buy HGH Fragment CJC-1295 DAC Blend Nasal Spray
HGH Fragment CJC-1295 DAC Blend nasal spray is a non-invasive delivery system of two popular growth hormone (GH) compounds responsible for fat loss. The peptides increase the overall amount of hormonal growth agent in the body, which studies have proven to burn body fat, particularly in the abdominal region.
HGH Fragment & CJC 1295 DAC 15ml Contains 2.5mg (HGH Fragment 176-191 = 1.7mg | CJC-1295 DAC = 0.8mg)
HGH Fragment & CJC 1295 DAC 30ml Contains 5mg (HGH Fragment 176-191 = 3.4mg | CJC-1295 DAC = 1.6mg)
HGH Fragment 176-191 CJC-1295 DAC Peptide Vial 2.5mg
HGH Fragment 176-191 CJC-1295 DAC Blend from Direct Anti Peptide is a precision-formulated dual-peptide vial supplied at ≥98% purity, combining 1.7mg of HGH Fragment 176-191 with 0.8mg of CJC-1295 DAC in a single lyophilized research vial. This blend is designed to support advanced laboratory investigation into growth hormone dynamics and lipolytic mechanisms. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Fragment 176-191 CJC-1295 no DAC
Buy HGH Fragment 176-191 CJC-1295 No DAC Blend Peptide Vial 2.5mg
Buy HGH Fragment 176-191 CJC-1295 No DAC Blend 2.5mg peptide vial as a research tool for investigating the effects of growth hormone modulation on fat metabolism, muscle preservation, and anti-aging therapies.
HGH Fragment 176-191 = 1.7mg | CJC-1295 No DAC = 0.8mg
Stock up & SAVE 10% on our Twin Packs
HGH Fragment 176-191 CJC-1295 No DAC Spray
HGH Fragment 176-191 CJC-1295 No DAC Spray from Direct Anti Peptide is a dual-peptide research formulation combining HGH Fragment 176-191 and CJC-1295 No DAC at ≥98% purity, presented in a convenient nasal spray delivery format. This blend is engineered exclusively for laboratory and scientific research environments, offering researchers a precisely dosed, analytically verified peptide combination. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Fragment 176-191 Nasal Spray
Direct Anti Peptide offers HGH Fragment 176-191 Nasal Spray, a ≥98% purity research peptide formulated for laboratory investigation into growth hormone receptor activity, adipose tissue metabolism, and lean mass research applications. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
HGH Fragment 176-191 Peptide Vial
HGH Fragment 176-191 is a synthetic 16-amino acid C-terminal segment of human growth hormone, available from Direct Anti Peptide at ≥98% purity as a lyophilized powder in a sterile glass vial. This research-grade peptide is of interest to scientists studying metabolic regulation, adipose tissue biology, and growth hormone-related mechanisms. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.